MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
KYMR Kymera Therapeutics
- 40.660
- +1.520+3.88%
Close Dec 20 16:00 ET
- 40.900
- +0.240+0.59%
Post 20:01 ET
2.63BMarket Cap-17.38P/E (TTM)
40.775High38.240Low1.15MVolume38.660Open39.140Pre Close46.28MTurnover2.64%Turnover RatioLossP/E (Static)64.77MShares53.27052wk High2.95P/B1.76BFloat Cap22.35052wk Low--Dividend TTM43.37MShs Float91.920Historical High--Div YieldTTM6.48%Amplitude9.600Historical Low40.382Avg Price1Lot Size
Kymera Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -58.59%-50.19M | -21.78%-42.94M | 9.95%-39.59M | 32.83%-102.83M | 120.35%8.05M | 7.65%-31.65M | 9.57%-35.26M | -9.12%-43.97M | -18.72%-153.09M | -3.09%-39.54M |
| Net income from continuing operations | -18.20%-62.49M | -8.41%-42.06M | -18.64%-48.56M | 5.07%-146.96M | 58.79%-14.37M | -22.94%-52.87M | 3.62%-38.8M | -11.57%-40.93M | -54.47%-154.81M | -2.85%-34.87M |
| Operating gains losses | ---- | ---- | -131.67%-3.07M | -688.19%-5.23M | ---- | ---- | ---- | -212.85%-1.33M | -84.74%889K | ---- |
| Depreciation and amortization | 122.01%1.99M | 115.33%1.94M | 66.21%1.46M | 19.75%3.57M | 8.92%891K | 16.69%895K | 27.66%900K | 27.95%879K | 24.20%2.98M | 18.72%818K |
| Change In working capital | -109.82%-971K | -84.44%-13.13M | 47.27%-6.32M | 107.13%2.68M | 188.14%11.89M | 1,039.83%9.89M | 26.84%-7.12M | 10.25%-11.98M | 39.24%-37.62M | 12.69%-13.49M |
| -Change in receivables | 12.21%386K | 140.77%327K | 2,236.91%16.73M | -575.80%-16.23M | -4,430.92%-14.99M | 167.06%344K | 27.49%-802K | 30.59%-783K | -284.98%-2.4M | -75.94%346K |
| -Change in prepaid assets | -857.81%-3.68M | 139.48%929K | -83.12%-3.01M | -97.68%-1.96M | 603.54%2.42M | 66.37%-384K | -293.50%-2.35M | -180.03%-1.64M | 75.30%-992K | 83.72%-480K |
| -Change in payables and accrued expense | -22.36%2.84M | 642.56%7.83M | -95.90%-15.32M | 9.35%5.22M | 975.45%8.32M | -51.63%3.66M | 612.84%1.06M | -110.50%-7.82M | -62.29%4.77M | -72.04%774K |
| -Change in other current assets | 245.63%2.53M | -7.09%852K | -45.61%619K | 827.85%4.8M | 1,346.04%2.01M | 450.38%732K | 627.78%917K | 856.30%1.14M | 23.39%517K | 21.93%139K |
| -Change in other current liabilities | -117.99%-1.1M | -77.21%1.51M | -9.57%2.64M | 1,950.80%18.58M | 1,192.86%2.91M | 2,463.32%6.12M | 2,734.52%6.64M | 1,384.14%2.92M | 1.08%-1M | -20.36%-266K |
| -Change in other working capital | -233.16%-1.95M | -95.51%-24.59M | -37.88%-7.98M | 79.94%-7.73M | 180.11%11.22M | 91.44%-585K | -27.49%-12.58M | 25.89%-5.79M | 45.95%-38.52M | 15.66%-14.01M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -58.59%-50.19M | -21.78%-42.94M | 9.95%-39.59M | 32.83%-102.83M | 120.35%8.05M | 7.65%-31.65M | 9.57%-35.26M | -9.12%-43.97M | -18.72%-153.09M | -3.09%-39.54M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -360.58%-157.68M | -56.35%15.64M | -1,444.81%-330.61M | 581.74%139.89M | 138.16%18.95M | 261.44%60.51M | -56.19%35.84M | -4.95%24.58M | 120.55%20.52M | 26.98%-49.67M |
| Net PPE purchase and sale | 102.34%189K | 56.45%-4.69M | -84.63%-7.4M | -1,115.80%-34.48M | -3,016.62%-11.63M | -548.31%-8.08M | -1,365.03%-10.77M | -731.74%-4.01M | -77.58%-2.84M | 25.55%-373K |
| Net investment purchase and sale | -330.17%-157.87M | -56.38%20.33M | -1,230.36%-323.21M | 646.59%174.37M | 162.03%30.58M | 289.29%68.59M | -43.53%46.61M | 8.53%28.59M | 123.77%23.36M | 26.99%-49.29M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -360.58%-157.68M | -56.35%15.64M | -1,444.81%-330.61M | 581.74%139.89M | 138.16%18.95M | 261.44%60.51M | -56.19%35.84M | -4.95%24.58M | 120.55%20.52M | 26.98%-49.67M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 121,904.85%250.92M | 8.20%1.41M | 30,422.52%353.76M | -97.26%4.19M | -0.97%1.93M | -100.14%-206K | 258.52%1.31M | 526.49%1.16M | -38.87%153M | -4.92%1.95M |
| Net issuance payments of debt | -88.53%-641K | -5.39%-352K | 11.31%-290K | 93.27%-76K | 403.28%925K | -16.44%-340K | -24.16%-334K | -23.86%-327K | -33.10%-1.13M | -95.51%-305K |
| Net common stock issuance | --246.51M | --0 | --350.11M | --0 | --0 | --0 | --0 | --0 | -38.37%149.83M | --0 |
| Proceeds from stock option exercised by employees | 3,670.90%5.05M | 7.63%1.76M | 164.67%3.93M | -0.84%4.27M | -55.31%1.01M | -86.10%134K | 158.93%1.64M | 230.96%1.49M | -48.88%4.3M | 0.85%2.26M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 121,904.85%250.92M | 8.20%1.41M | 30,422.52%353.76M | -97.26%4.19M | -0.97%1.93M | -100.14%-206K | 258.52%1.31M | 526.49%1.16M | -38.87%153M | -4.92%1.95M |
| Net cash flow | ||||||||||
| Beginning cash position | 26.24%73.45M | 76.44%99.34M | 55.36%115.78M | 37.77%74.53M | -46.32%86.85M | -29.92%58.19M | 41.30%56.3M | 37.77%74.52M | 65.96%54.09M | 2.12%161.77M |
| Current changes in cash | 50.21%43.05M | -1,470.87%-25.88M | 9.78%-16.44M | 101.89%41.25M | 133.16%28.93M | -63.61%28.66M | -95.63%1.89M | -27.92%-18.23M | -4.96%20.43M | 16.36%-87.25M |
| End cash Position | 34.15%116.5M | 26.24%73.45M | 76.44%99.34M | 55.35%115.78M | 55.35%115.78M | -46.32%86.85M | -29.92%58.19M | 41.30%56.3M | 37.77%74.53M | 37.77%74.53M |
| Free cash flow | -25.87%-50M | -3.48%-47.63M | 2.05%-46.99M | 11.94%-137.31M | 91.03%-3.58M | -11.85%-39.73M | -15.87%-46.02M | -17.66%-47.98M | -19.44%-155.92M | -2.72%-39.91M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.